Hi-Tech Pharmacal Receives FDA Approval to Market Generic Form of Phenergan Syrup.AMITYVILLE, N.Y.--(BUSINESS WIRE)--Oct. 1, 1998--Hi-Tech Pharmacal Co. Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : HITK) has received ANDA ANDA abbr. abbreviated new drug application approval from the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for Promethazine Hydrochloride Syrup USP USP - unique sales point , 6.25 mg/5 mL, equivalent to Phenergan Syrup Plain, 6.25 mg/5 mL, by Wyeth Ayerst Laboratories Inc. This approval adds to Hi-Tech's line of Promethazine promethazine /pro·meth·a·zine/ (-meth´ah-zen) a phenothiazine derivative, used in the form of the hydrochloride salt as an antihistaminic, antiemetic, antivertigo agent, and sedative, and in the prevention and treatment of motion products including Promethazine HCL and Codeine Phosphate Syrup, and Promethazine HCL and Dextromethorphan Hydrobromide Syrup. The company is confident that this approval trend will continue and looks forward to receiving approvals on the exciting pipeline of new products currently in various stages of development at Hi-Tech. Hi-Tech Pharmacal Co. Inc. is a growing manufacturer and marketer of prescription, over-the-counter and nutritional products under various brand names such as H-T and Rx Choice, as well as a broad line of branded products - Diabetic Tussin, DiabetiDerm, DiabetiSweet, Nasal Ease - designed for the diabetic and general health marketplace. These products are sold in liquid and semi-solid (creams, ointments, suppositories suppositories, n.pl solid capsules made of materials that melt at body temperature and are used to deliver medicinal substances into the rectum. and gels) dosage forms. The company also is a leading manufacturer of sterile ophthalmic, otic and inhalation products and provides sterile manufacturing contract services. This release contains forward looking statements that are subject to risks and uncertainties, including but not limited to the impact of competitive products and pricing, product demand and market acceptance, new product development, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion